Live Breaking News & Updates on Rafiq Maqbool Associated|Page 4

MUMBAI, India   
As India launches an ambitious effort to vaccinate 300 million people against the coronavirus within six months, it is employing two vaccines both manufactured domestically but approved under very different circumstances.
One is CoviShield, the vaccine developed by Britain’s AstraZeneca and Oxford University, which clinical trials show is about 70% effective in preventing COVID-19 and is being manufactured in India by the Serum Institute, the country’s largest drugmaker.
The other is Covaxin, developed by an Indian company in conjunction with the government but whose performance in late-stage clinical trials has yet to be published. Health authorities nevertheless approved the vaccine for “restricted emergency use.” ....

United States , United Kingdom , Tamil Nadu , West Bengal , Anant Phadke , Prashant Yadav , K Sujatha Rao , Chandra Mohan , Bhagwan Pawar , Narendra Modi , Avinash Bhondve , Rajesh Bhushan , International Monetary Fund , Bikas Das Associated , Global Development , Serum Institute , Rafiq Maqbool Associated , Oxford University , Secretary Rajesh Bhushan , Bikas Das , Associated Press , Minister Narendra Modi , Hyderabad Based Bharat Biotech , Rafiq Maqbool , Indian Medical , ஒன்றுபட்டது மாநிலங்களில் ,